You are now leaving www.kedplasma.hu. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
About Kedrion - Front Image

About us

KEDPLASMA MAGYARORSZÁG is part of Human BioPlazma, a company based in Gödöllő, Hungary, that collects and fractionates blood plasma to produce and distribute plasma-derived medicinal products for use in treating often rare diseases, disorders and conditions such as hemophilia and immune system deficiencies. All of the plasma collected by KEDPLASMA MAGYARORSZÁG goes to Human BioPlazma and all of the resulting medicines are used to satisfy the needs of Hungarians before the remainder is distributed to other countries.

Human BioPlazma is a subsidiary of Kedrion Biopharma, an international company specialized in producing and distributing plasma-derived therapies in more than 90 countries. Kedrion was established in Italy in 2001, but the roots of the companies from which it was born stretch back several decades in the production of blood and plasma-derived products. It was and is a family-owned business that places a high value not only on the welfare of those who benefit from their products but on the people and communities where Kedrion works.

As a partner to the Italian National Health System, Kedrion has helped that country – as well as Hungary - toward self-sufficiency in plasma-derived products and it brings both this experience and the dedication to that goal to other potential partners around the world. In recent years Kedrion has substantially expanded its operations and markets, most signicantly in Hungary, Germany and the United States among other countries. It has acquired collection and production capacity as well as the rights to significant products such as RhoGAM®, which effectively prevents hemolytic disease of the newborn.

Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived products in healthcare systems and communities around the world and to improve the lives of people suffering from rare disorders and conditions.